Last Close
Feb 27  •  04:00PM ET
36.38
Dollar change
-0.20
Percentage change
-0.53
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y50.68% Total Holdings40 Perf Week-0.06%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM95.65M Perf Month1.40%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter-1.85%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High40.10 -9.28% Perf Half Y30.45%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 93.70% Perf YTD-0.65%
Active/Passive Quant Type Tagsmedical Flows% 1M4.77% Volatility1.19% 1.80% Perf Year51.51%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M8.59% ATR (14)0.79 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD3.61% RSI (14)51.52 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.36 Perf 10Y-
Expense0.54% Growth/Value SMA201.02% Flows% 3Y Rel Volume5.82 Prev Close36.57
Inverse/Leveraged Market Cap SMA50-0.56% Flows% 5Y Avg Volume7.42K Price36.38
IPOOct 31, 2024 Option/ShortNo / Yes SMA20019.84% Trades Volume43,210 Change-0.53%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.